Anja Specht, Linda T Betz, Antje Riepenhausen, Kamila Jauch-Chara, Gitta A Jacob, Dieter Riemann, Robert Göder
{"title":"Effectiveness and safety of an interactive internet-based intervention to improve insomnia: Results from a randomised controlled trial.","authors":"Anja Specht, Linda T Betz, Antje Riepenhausen, Kamila Jauch-Chara, Gitta A Jacob, Dieter Riemann, Robert Göder","doi":"10.1111/jsr.14409","DOIUrl":null,"url":null,"abstract":"<p><p>Many adults suffer from insomnia. Cognitive-behavioural therapy for insomnia is the recommended treatment option, but access to it is not readily available. Digital interventions have the potential to close the treatment gap by offering scalable and cost-efficient options. The present randomised controlled trial aimed at investigating the effectiveness and safety of somnovia, an interactive internet-based intervention for patients with insomnia. A total of 290 participants with chronic insomnia were randomised to intervention (n = 149) or the control (n = 141) condition. Participants of the intervention group received access to somnovia for 6 months in addition to treatment as usual, whereas participants in the control group only had access to treatment as usual for the time of the study. Online questionnaires were filled in before randomisation and after 3 and 6 months. The primary endpoint was the Insomnia Severity Index, with the Patient Health Questionnaire-9, the Generalised Anxiety Disorder Assessment-7, and the Work and Social Adjustment Scale as secondary endpoints. After 3 months, the intervention group showed lower insomnia (Cohen's d = 0.71, CI = [0.44, 0.98]), depressive (Cohen's d = 0.66, CI = [0.41, 0.90]), and anxiety (Cohen's d = 0.56, CI = [0.32, 0.81]) symptoms, as well as improved overall functioning (Cohen's d = 0.50, CI = [0.24, 0.76]) compared with participants in the control group. The effects stayed stable after 6 months. The results indicate that next to a therapeutic effect on insomnia symptoms, somnovia might potentially help to prevent the onset of other psychiatric disorders such as depression and anxiety.</p>","PeriodicalId":17057,"journal":{"name":"Journal of Sleep Research","volume":" ","pages":"e14409"},"PeriodicalIF":3.4000,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Sleep Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/jsr.14409","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
许多成年人都患有失眠症。失眠症的认知行为疗法是推荐的治疗方案,但并不容易获得。数字干预方法具有可扩展性和成本效益,有望缩小治疗差距。本随机对照试验旨在研究 somnovia 的有效性和安全性,这是一种针对失眠症患者的互动式互联网干预措施。共有 290 名慢性失眠患者被随机分配到干预组(149 人)或对照组(141 人)。干预组的参与者除了接受常规治疗外,还可在 6 个月内使用 somnovia,而对照组的参与者在研究期间只能接受常规治疗。随机分组前以及 3 个月和 6 个月后填写在线问卷。主要终点是失眠严重程度指数,次要终点是患者健康问卷-9、广泛性焦虑症评估-7 和工作与社会适应量表。3 个月后,与对照组相比,干预组的失眠(Cohen's d = 0.71,CI = [0.44,0.98])、抑郁(Cohen's d = 0.66,CI = [0.41,0.90])和焦虑(Cohen's d = 0.56,CI = [0.32,0.81])症状有所减轻,整体功能也有所改善(Cohen's d = 0.50,CI = [0.24,0.76])。6 个月后,疗效保持稳定。结果表明,除了对失眠症状有治疗作用外,索姆诺维亚还可能有助于预防抑郁症和焦虑症等其他精神疾病的发生。
Effectiveness and safety of an interactive internet-based intervention to improve insomnia: Results from a randomised controlled trial.
Many adults suffer from insomnia. Cognitive-behavioural therapy for insomnia is the recommended treatment option, but access to it is not readily available. Digital interventions have the potential to close the treatment gap by offering scalable and cost-efficient options. The present randomised controlled trial aimed at investigating the effectiveness and safety of somnovia, an interactive internet-based intervention for patients with insomnia. A total of 290 participants with chronic insomnia were randomised to intervention (n = 149) or the control (n = 141) condition. Participants of the intervention group received access to somnovia for 6 months in addition to treatment as usual, whereas participants in the control group only had access to treatment as usual for the time of the study. Online questionnaires were filled in before randomisation and after 3 and 6 months. The primary endpoint was the Insomnia Severity Index, with the Patient Health Questionnaire-9, the Generalised Anxiety Disorder Assessment-7, and the Work and Social Adjustment Scale as secondary endpoints. After 3 months, the intervention group showed lower insomnia (Cohen's d = 0.71, CI = [0.44, 0.98]), depressive (Cohen's d = 0.66, CI = [0.41, 0.90]), and anxiety (Cohen's d = 0.56, CI = [0.32, 0.81]) symptoms, as well as improved overall functioning (Cohen's d = 0.50, CI = [0.24, 0.76]) compared with participants in the control group. The effects stayed stable after 6 months. The results indicate that next to a therapeutic effect on insomnia symptoms, somnovia might potentially help to prevent the onset of other psychiatric disorders such as depression and anxiety.
期刊介绍:
The Journal of Sleep Research is dedicated to basic and clinical sleep research. The Journal publishes original research papers and invited reviews in all areas of sleep research (including biological rhythms). The Journal aims to promote the exchange of ideas between basic and clinical sleep researchers coming from a wide range of backgrounds and disciplines. The Journal will achieve this by publishing papers which use multidisciplinary and novel approaches to answer important questions about sleep, as well as its disorders and the treatment thereof.